Avilar Therapeutics
Signal active
Organization
Contact Information
Overview
Avilar Therapeutics is a biopharmaceutical company focusing on the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation.
About
Industries
Biotechnology, Pharmaceutical, Medical
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Avilar Therapeutics headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $1.8B in funding across 24 round(s). With a team of 11-50 employees, Avilar Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Avilar Therapeutics, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
4
Lead Investors
0
Total Funding Amount
$75.0M
Details
2
Avilar Therapeutics has raised a total of $75.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 60.0M | ||
| 2023 | Seed | 15.0M |
Investors
Avilar Therapeutics is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Tess Cameron | - | FUNDING ROUND - Tess Cameron | 15.0M |
| Milind Deshpande | - | FUNDING ROUND - Milind Deshpande | 15.0M |
| Avilar Therapeutics | - | FUNDING ROUND - Avilar Therapeutics | 15.0M |
| RA Capital Management | - | FUNDING ROUND - RA Capital Management | 15.0M |
Recent Activity
There is no recent news or activity for this profile.